Acute abdomen due to endometriosis in a premenopausal woman taking tamoxifen

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 109, Issue 2, 2003, Pages 234-235

  De Velasco, Lorenzo Abad ^a   Cano, Antonio ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Acute abdomen; Endometriosis; Tamoxifen

Indexed keywords

TAMOXIFEN;

ACUTE ABDOMEN; ADULT; ARTICLE; BREAST CARCINOMA; CARCINOMA IN SITU; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ENDOMETRIOSIS; FEMALE; HUMAN; HYSTERECTOMY; LABORATORY TEST; PREMENOPAUSE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0038691515     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00004-6     Document Type: Article

References (10)

1. Early Breast Cancer Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials, Lancet 1998;351:1451-67.
2. Fisher B., Costantino J.P., Wickerham D.L., Redmond C.K., Kavanah M., Cronin W.M.et al. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J. Natl. Cancer Inst. 90:1998;1371-1388.
3. Cano A., Hermenegildo C. The endometrial effects of SERMs. Hum. Reprod. Update. 6:2000;244-254.
4. American Fertility Society. Revised American Fertility Society classification: 1985. Fertil Steril 1985;43:351-2.
5. Ford M.R.W., Turner J.J., Wood C., Soutter W.P. Endometriosis developing during tamoxifen therapy. Am. J. Obstet. Gynecol. 158:1988;1119.
6. Cano A., Matallín P., Legua V., Tortajada M., Bonilla-Musoles F. Tamoxifen and the uterus and endometrium. Lancet. i:1989;376.
7. Cohen I., Altaras M.M., Lew S., Beyth Y., Ben-Baruch G. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature. Gynecol. Oncol. 55:1994;443-447.
8. Rose P.G., Alvarez B., MacLennan T. Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure. Am. J. Obstet. Gynecol. 183:2000;507-508.
9. Powles T.J., Bourne T., Athanasiou S., Chang J., Grubock K., Ashley S.et al. The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. Br. J. Cancer. 78:1998;272-275.
10. Barbieri R.L. Endometriosis and the estrogen threshold theory. Relation to surgical and medical treatment. J. Reprod. Med. 43:1998;287-292.